SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 6,795.86 |
| Enterprise Value ($M) | 5,983.19 |
| Book Value ($M) | 754.38 |
| Book Value / Share | 34.17 |
| Price / Book | 9.01 |
| NCAV ($M) | 745.06 |
| NCAV / Share | 33.74 |
| Price / NCAV | 9.12 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.53 |
| Return on Assets (ROA) | -0.43 |
| Return on Equity (ROE) | -0.55 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 5.90 |
| Current Ratio | 6.10 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 1,032.93 |
| Assets | 1,042.25 |
| Liabilities | 287.86 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 180.13 |
| Operating Income | -497.88 |
| Net Income | -465.89 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -455.57 |
| Cash from Investing | -274.39 |
| Cash from Financing | 735.06 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Janus Henderson Group Plc | 10.10 | -23.90 | |
| 13G | Rtw Investments, Lp | 9.20 | ||
| 13G/A | Paulson & Co. Inc. | 9.40 | 84.67 | |
| 13D/A | Baker Bros. Advisors Lp | 9.99 | 4.17 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 54,232 | 207,222 | 26.17 | |
| 136,317 | 456,961 | 29.83 | |
| 30,385 | 140,796 | 21.58 | |
| 41,579 | 193,859 | 21.45 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| LXRX – Lexicon Pharmaceuticals, Inc. | LYEL – Lyell Immunopharma, Inc. |
| MCRB – Seres Therapeutics, Inc. | MGNX – MacroGenics, Inc. |
| MGTX – MeiraGTx Holdings plc |
Financial data and stock pages provided by
Fintel.io